Cross acquires Micromacinazione

The GP invested alongside the existing management team as part of a succession plan for the previous private owners.

Cross will focus on growing the mid-cap company by entering new markets, broadening the customer base and developing technologies. The GP also plans to make add-on acquisitions.

Debt
Debt was arranged with a Swiss bank.

Company
Micromacinazione was founded in 1970 and is headquartered in Molinazzo di Monteggio but based in Ticino. It employs 100 people and has a turnover of around CHF20m.

The company manufactures technology and provides services for the micronisation of bulk active pharmaceutical ingredients (API). Customers include Swiss and international pharmaceutical companies.

People
Markus Reich is partner at Cross. The company's CEO and minority shareholder is Luca Bolzani. Martin Riediker was brought in by the GP as chairman of the board of directors.

Advisers
Equity - Altium Capital, Carlo Dawan, Alessandro Soprano, Emilio Pestarino (M&A); Wenger & Vieli, Wolfgang Zuercher, Michael Mosimann (Legal); Molo Avvocati, Mattia Tonella (Legal); Ernst & Young, Stefan Roesch, Simon Sterchi (Financial due diligence); Georg Lutz, Gernot Zitter (Tax); L.E.K. Consulting, Giovanni Calia, Filippo Cerrone (Commercial due diligence); Kessler & Co, Klaus Peretti (Insurance & pension due diligence); CSD Ingegneri, Roberto Rossi, Antoine Indaco (Environmental due diligence); Autentica & Partners, Omar Antonelli (Real estate due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Buyouts
• Switzerland
• Cross Equity Partners AG
• Ernst & Young